Tag: FDA digital health guidance

Digital Health and eConsent in U.S. Clinical Trials: Regulatory Guidance and Implementation

Posted on digi By digi

Digital Health and eConsent in U.S. Clinical Trials: Regulatory Guidance and Implementation Integrating Digital Health and eConsent into U.S. Clinical Trials: Regulatory and Practical Insights Introduction The adoption of digital health technologies (DHTs) and electronic informed consent (eConsent) has transformed the conduct of U.S. clinical trials. These innovations increase accessibility, streamline recruitment, and enhance patient…

Read More “Digital Health and eConsent in U.S. Clinical Trials: Regulatory Guidance and Implementation” »

Clinical Trials in USA, Country-Specific Clinical Trials

Navigating FDA and EMA Guidelines for Digital Health Tools in Clinical Trials

Posted on digi By digi

Navigating FDA and EMA Guidelines for Digital Health Tools in Clinical Trials Understanding FDA and EMA Regulations for Digital Health Tools Introduction: The Rise of Digital Health in Clinical Research Digital health tools—including wearable devices, mobile apps, and AI-driven sensors—are rapidly transforming clinical trials. These technologies offer real-time data capture, remote monitoring, and improved patient…

Read More “Navigating FDA and EMA Guidelines for Digital Health Tools in Clinical Trials” »

AI, Big Data, and Technology in Clinical Trials, Wearable Devices and Sensors

FDA Guidance on Digital Health Technologies in Clinical Trials

Posted on digi By digi

FDA Guidance on Digital Health Technologies in Clinical Trials Understanding FDA’s Expectations for Digital Health Tools in Trials Introduction: Digital Health and Regulatory Scrutiny As sponsors increasingly adopt digital health technologies (DHTs) like wearables, biosensors, and mobile apps in clinical trials, the U.S. Food and Drug Administration (FDA) has released specific guidance to help industry…

Read More “FDA Guidance on Digital Health Technologies in Clinical Trials” »

Regulatory Considerations, Wearables and Digital Endpoints

Patient Privacy in Digital Biomarker Collection

Posted on digi By digi

Patient Privacy in Digital Biomarker Collection Safeguarding Patient Privacy in the Era of Digital Biomarkers Introduction: The Privacy Paradox in Wearable Biomarker Trials Digital biomarkers collected via wearables and mobile sensors offer powerful insights into patient health. However, they also raise serious concerns about patient privacy. Continuous data capture, GPS location, behavioral metrics, and physiological…

Read More “Patient Privacy in Digital Biomarker Collection” »

Digital Biomarkers, Wearables and Digital Endpoints

Digital Health Regulations by the FDA: A Comprehensive Guide for Innovators

Posted on digi By digi

Digital Health Regulations by the FDA: A Comprehensive Guide for Innovators Navigating FDA Digital Health Regulations: What Innovators Need to Know Digital health technologies—ranging from mobile apps and wearables to AI-driven clinical decision support systems—are revolutionizing healthcare. As innovation accelerates, the U.S. Food and Drug Administration (FDA) plays a central role in regulating digital health…

Read More “Digital Health Regulations by the FDA: A Comprehensive Guide for Innovators” »

Regulatory Guidelines, U.S. FDA Regulations